Error: Could not add to watchlist. X

Alkermes PLC

+ Watchlist
ALKS:US
NASDAQ GS
61.03
USD
0.70
1.16%
As of 20:10:00 ET on 06/02/2015.
Open
60.34
Day Range
59.73 - 61.81
Volume
842,430
Previous Close
60.33
52Wk Range
38.49 - 75.17
1 Yr Return
29.66%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.64
Market Cap (b USD)
9.071
Shares Outstanding (m)
148.631
Price/Sales (TTM)
13.76
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma
Profile
Alkermes PLC researches pharmaceuticals. The Company develops treatments for central nervous system disorders such as addiction, schizophrenia and depression, and diabetes.
ADDRESS
Athlone
Ireland
PHONE
353-9064-95000
  • Richard F Pops
    Chairman/CEO
  • Shane M Cooke
    President
  • James M Frates "Jim"
    Senior VP/CFO/Treasurer
  • Gordon G Pugh
    Senior VP/COO/Chief Risk Ofcr
  • Mark Stejbach
    Senior VP/Chief Commercial Ofcr
Show More